Integra LifeSciences Holdings (IART)

Financial leverage ratio

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Total assets	US$ in thousands	3,781,990	3,889,760	3,782,380	3,615,140	3,303,240
Total stockholders’ equity	US$ in thousands	1,587,880	1,804,400	1,684,800	1,514,870	1,416,740
Financial leverage ratio		2.38	2.16	2.25	2.39	2.33

December 31, 2023 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $3,781,990K ÷ $1,587,880K
= 2.38

The financial leverage ratio of Integra Lifesciences Holdings Corp has exhibited some fluctuations over the past five years. It increased from 2.33 in 2019 to 2.39 in 2020, indicating a slightly higher level of leverage. However, there was a decrease in the ratio to 2.25 in 2021 followed by a subsequent increase to 2.16 in 2022 and further up to 2.38 in 2023.

Overall, the company's financial leverage ratio has remained above 2 for the majority of the period under review, suggesting that Integra Lifesciences Holdings Corp relies more on debt financing compared to equity. The fluctuations in the ratio may indicate changes in the company's capital structure and financing decisions over the years. It is essential for stakeholders to closely monitor these changes to assess the company's risk exposure and financial stability.